期刊文献+

Lasp1 mRNA和蛋白在口腔鳞癌组织中表达上升及其临床意义 被引量:5

Increased Expression of Lasp1 mRNA and Protein in Oral Squamous Cell Carcinoma Tissues with Their Clinical Significance.
下载PDF
导出
摘要 目的:探讨Lasp1基因与蛋白质水平在口腔鳞状细胞癌(OSCC)组织标本中的表达及其临床意义。方法:分别采用荧光实时定量RT-PCR和免疫组织化学方法,检测Lasp1在30例口腔鳞癌患者的癌组织及癌旁组织标本中mRNA和蛋白质表达水平,其表达水平与临床病理指标之间的关系采用SPSS10.0软件包进行统计分析。结果:口腔鳞癌组织标本中Lasp1 mRNA和蛋白质表达水平均显著高于癌旁组织(P<0.01)。Lasp1蛋白在临床晚期、淋巴结转移阳性病例中表达明显升高,与烟酒嗜好、肿瘤大小及肿瘤分化程度无关。结论:Lasp1在口腔鳞状细胞癌中表达上调,可能与肿瘤的发生、发展和淋巴结转移有关,可以作为一个潜在的生物标志物和治疗的靶标。 Objective: To investigate the gene transcript level and protein expression of Lasp1 in oral squamous cell carcinoma tissues as well as their clinical significance.Methods: The mRNA level and protein expression of Lasp1 in 30 cases of oral squamous cell carcinoma tissues and paracancerous tissues were detected by fluorescent quantitive real-time RT-PCR and immunohistochemistry techniques respectively.The relationship between the Lasp1 expression level and the clinicopathological parameters was analyzed by SPSS10.0 software package.Results: The Lasp1 mRNA transcript level and protein expression in cancerous tissues increased significantly compared to the paracancerous tissues.Though no significant correlation was found between Lasp1 expression and smoking,drinking,T stage and pathological differential degree,OSCC patients with more advanced clinical stages and lymph node metastasis were prone to have higher expression of Lasp1.Conclusion: The results suggest that increased expression of Lasp1 contributes to cancerous progression and lymph node metastasis,and Lasp1 may be potentially used as a biomarker and a therapeutic target for OSCC.
出处 《口腔医学研究》 CAS CSCD 北大核心 2011年第1期37-39,43,共4页 Journal of Oral Science Research
基金 国家自然科学基金资助项目(编号:30630065) 浙江省自然科学基金资助项目(编号:Y2091171)
关键词 口腔鳞状细胞癌 Lasp1 基因表达 实时定量RT-PCR 免疫组织化学 Oral squamous cell carcinoma LIM and SH3 domain protein 1 Gene expression Quantitive real-time RT-PCR Immunohistochemistry
  • 相关文献

参考文献12

  • 1Tomasetto C,Regnier C,Moog-Lutz C,et al.Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21,3 region of chromosome 17[J].Genomics,1995,28(3):367-376. 被引量:1
  • 2Grunewald TG,Kammerer U,Winkler C,et al.Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences Zyxin localisation[J].Br J Cancer,2007,96(2):296-305. 被引量:1
  • 3Dimova I,Orsetti B,Negre V,et al.Genomic markers for ovarian cancer at chromosomes 1,8 and 17 revealed by array CGH analysis[J].Tumori,2009,95(3):357-366. 被引量:1
  • 4Wang B,Feng P,Xiao Z,et al.LIM and SH3 protein 1 (Laspl) is a novel p53 transcriptional target involved in hepatocellular carcinoma[J].J Hepatol,2009,50(3):528-537. 被引量:1
  • 5Petersen PE.The World Oral Health Report 2003:continuous improvement of orsl health in the 21st century-the approach of WHO Global Oral Programme[J].Community Dent Oral Epidemiol,2003,31(Suppl.):3-23. 被引量:1
  • 6Neville BW,Day TA.Oral cancer and precancerous lesions[J].CA Cancer J Clin,2002,52(4):195-215. 被引量:1
  • 7Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method[J].Methods,2001,25(4):402-408. 被引量:1
  • 8Li B,Zhuang L,Trueb B.Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1[J].J Biol Chem,2004,279(19):20401-20410. 被引量:1
  • 9Rachlin AS,Otey CA.Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin[J].J Cell Sci,2006,119(Pt 6):995-1004. 被引量:1
  • 10Okamoto CT,Li R,Zhang Z,et al.Regulation of protein and vesicle trafficking at the apical membrane of epithelial cells[J].J Control Release,2002,78(1-3):35-41. 被引量:1

同被引文献37

  • 1周英琼,曾思恩,侯巧燕,陆明深,张美艳.P-gp、GST-Л、p53和CD44v6在肺癌中的表达[J].肿瘤防治研究,2005,32(11):699-701. 被引量:2
  • 2陈谦明.口腔粘膜病学[M].第3版.北京:人民卫生出版社,2008:58-68. 被引量:11
  • 3Kabanov AV , Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer [J]. Adv Drug Deliv Rev, 2002, 54(5) : 759--779. 被引量:1
  • 4Tsuruo T, Naito M, Tomida A, et al. Molecular argeting therapy of cancer:drug resistance, apoptosis and survival sig- nal [J]. Cancer Sci, 2003, 94(1): 15--21. 被引量:1
  • 5Fojo AT , Ueda K, Slamon DJ , et al. Expression of a multi- drug resistance gene in human tumors and tissues [J]. Pro- ceedings of the National Academy of Sciences(USA) , 1987, 84(1) : 265--269. 被引量:1
  • 6Camassei FD ,Arancia G,Cianf riglia M , et al. Nephroblas- toma : muhidrug--resistance P--glyeoprotein expression in tumor cells and intratumoral capillary endotholial cells [J]. Am J ClinPathol, 2002, 117(3) : 484--490. 被引量:1
  • 7Lacueva FJ , Calpena R, Medrano J, et al. Changes in P-- glycoprotein expression in gastril carcinoma with respect to distant gastric mucosa may be influenced by p53 [J]. Cancer, 2000, 89 (1): 21--28. 被引量:1
  • 8Jonker JW, Buitelaar M, Wagenaar E, et al. The breast cancer resistance protein protects against a major chlorophyll --derived dietary phototoxin and protoporphyria [J]. Proc Natl Acad Sci USA, 2002, 99(24): 15649--15654. 被引量:1
  • 9Zhang W, Shannon WD, Duncan J, et al. Expression of drug pathway proteins is independent of tumor type [J]. J Pathol, 2006, 209 (2) :213--219. 被引量:1
  • 10Allikmets R, Schriml LM, Hutchinson A, et al. A human placenta-- specific ATP-- binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrng resistance [J]. CancerRes, 1998, 58(23) : 5337--5339. 被引量:1

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部